US Stock MarketDetailed Quotes

PBLA Panbela Therapeutics

Watchlist
  • 0.370
  • +0.003+0.68%
15min DelayClose Nov 1 16:00 ET
1.80MMarket Cap0.00P/E (TTM)

Panbela Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Panbela Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 13, 20242024/Q20.000 / 0.000--
May 15, 20242024/Q10.000 / 0.000--
Mar 26, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
Aug 10, 20232023/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
Aug 13, 20242024/Q20.000 / 0.000--
May 15, 20242024/Q10.000 / 0.000--
Mar 26, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
Aug 10, 20232023/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Panbela Therapeutics Earnings Reports

  • Panbela Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 17:13 ET

  • Panbela Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 15 22:28 ET

  • Panbela Therapeutics | 10-K: FY2023 Annual Report

    Mar 26 16:20 ET

  • Panbela Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 2, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data